Computational selection of RNA aptamer against angiopoietin-2 and experimental evaluation

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Hu, Wen Pin ^a,b   Kumar, Jangam Vikram ^a   Huang, Chun Jen ^c   Chen, Wen Yih ^c  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; APTAMER; ANGPT2 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; COMPUTER MODEL; POINT MUTATION; PREDICTION; PROTEIN BINDING; PROTEIN INTERACTION; RNA SEQUENCE; SCORING SYSTEM; SEQUENCE ANALYSIS; SIMULATION; SURFACE PLASMON RESONANCE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER SIMULATION; HUMAN;

ANGIOPOIETIN-2; APTAMERS, NUCLEOTIDE; COMPUTER SIMULATION; HUMANS; SELEX APTAMER TECHNIQUE; SURFACE PLASMON RESONANCE;

EID: 84926512808     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/658712     Document Type: Article

References (30)

1. P. C. Maisonpierre, C. Suri, P. F. Jones et al., "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis," Science, Vol. 277, no. 5322, pp. 55-60, 1997.
2. J. Holash, P. C. Maisonpierre, D. Compton et al., "Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF," Science, Vol. 284, no. 5422, pp. 1994-1998, 1999.
3. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, "Vascular-specific growth factors and blood vessel formation," Nature, Vol. 407, no. 6801, pp. 242-248, 2000.
4. J. L. Brown, Z. A. Cao, M. Pinzon-Ortiz et al., "A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models," Molecular Cancer Therapeutics, Vol. 9, no. 1, pp. 145-156, 2010.
5. H. Hashizume, B. L. Falcón, T. Kuroda et al., "Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth," Cancer Research, Vol. 70, no. 6, pp. 2213-2223, 2010.
6. P. Nasarre, M. Thomas, K. Kruse et al., "Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth," Cancer Research, Vol. 69, no. 4, pp. 1324-1333, 2009.
7. H. Huang, A. Bhat, G. Woodnutt, and R. Lappe, "Targeting the ANGPT-TIE2 pathway in malignancy," Nature Reviews Cancer, Vol. 10, no. 8, pp. 575-585, 2010.
8. R. Mazzieri, F. Pucci, D. Moi et al., "Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells," Cancer Cell, Vol. 19, no. 4, pp. 512-526, 2011.
9. S. Tombelli, M. Minunni, and M. Mascini, "Analytical applications of aptamers," Biosensors and Bioelectronics, Vol. 20, no. 12, pp. 2424-2434, 2005.
10. S. Tombelli, M. Minunni, and M. Mascini, "Aptamers-based assays for diagnostics, environmental and food analysis," Biomolecular Engineering, Vol. 24, no. 2, pp. 191-200, 2007.
11. J. Wang, R. Lv, J. Xu, D. Xu, and H. Chen, "Characterizing the interaction between aptamers and human IgE by use of surface plasmon resonance," Analytical and Bioanalytical Chemistry, Vol. 390, no. 4, pp. 1059-1065, 2008.
12. Y. H. Kim, J. P. Kim, S. J. Han, and S. J. Sim, "Aptamer biosensor for lable-free detection of human immunoglobulin E based on surface plasmon resonance," Sensors and Actuators, B: Chemical, Vol. 139, no. 2, pp. 471-475, 2009.
13. R. R. White, S. Shan, C. P. Rusconi et al., "Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2," Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, no. 9, pp. 5028-5033, 2003.
14. S. Sarraf-Yazdi, J. Mi, B. J. Moeller et al., "Inhibition of In Vivo Tumor Angiogenesis and Growth Via Systemic Delivery of an Angiopoietin 2-Specific RNA Aptamer," Journal of Surgical Research, Vol. 146, no. 1, pp. 16-23, 2008.
15. Y. Chushak and M. O. Stone, "In silico selection of RNA aptamers," Nucleic Acids Research, Vol. 37, no. 12, article e87, 2009.
16. A. Bini, M. Mascini, M. Mascini, and A. P. F. Turner, "Selection of thrombin-binding aptamers by using computational approach for aptasensor application," Biosensors and Bioelectronics, Vol. 26, no. 11, pp. 4411-4416, 2011.
17. S. Qin and H.-X. Zhou, "Structural models of protein-DNA complexes based on interface prediction and docking," Current Protein and Peptide Science, Vol. 12, no. 6, pp. 531-539, 2011.
18. 2PE: protein interface/interior prediction engine," Nucleic Acids Research, Vol. 35, no. 2, pp. W357-W362, 2007.
19. R. R. White, J. A. Roy, K. D. Viles, B. A. Sullenger, and C. D. Kontos, "A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function," Angiogenesis, Vol. 11, no. 4, pp. 395-401, 2008.
20. K. Sato, M. Hamada, K. Asai, and T. Mituyama, "CentroidFold: a web server for RNA secondary structure prediction," Nucleic Acids Research, Vol. 37, no. 2, pp. W277-W280, 2009.
21. M. Popenda, M. Szachniuk, M. Antczak et al., "Automated 3D structure composition for large RNAs," Nucleic Acids Research, Vol. 40, no. 14, article e112, 2012.
22. W. A. Barton, D. Tzvetkova-Robev, E. P. Miranda et al., "Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex," Nature Structural and Molecular Biology, Vol. 13, no. 6, pp. 524-532, 2006.
23. M. C. Lawrence and P. M. Colman, "Shape complementarity at protein/protein interfaces," Journal of Molecular Biology, Vol. 234, no. 4, pp. 946-950, 1993.
24. V. C. Epa and P. M. Colman, "Shape and electrostatic complementarity at viral antigen-antibody complexes," Current Topics in Microbiology and Immunology, Vol. 260, pp. 45-53, 2001.
25. S. B. Long, M. B. Long, R. R. White, and B. A. Sullenger, "Crystal structure of an RNA aptamer bound to thrombin," RNA, Vol. 14, no. 12, pp. 2504-2512, 2008.
26. J. V. Kumar, W.-Y. Chen, J. J. P. Tsai, and W.-P. Hu, "Molecular simulation methods for selecting thrombin-binding aptamers," Lecture Notes in Electrical Engineering, Vol. 253, pp. 743-749, 2013.
27. W.-P. Hu, G.-L. Chang, S.-J. Chen, and Y.-M. Kuo, "Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing," Journal of Neuroscience Methods, Vol. 154, no. 1-2, pp. 190-197, 2006.
28. W. A. Barton, D. Tzvetkova, and D. B. Nikolov, "Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition," Structure, Vol. 13, no. 5, pp. 825-832, 2005.
29. G. Schreiber, "Kinetic studies of protein-protein interactions," Current Opinion in Structural Biology, Vol. 12, pp. 41-47, 2002.
30. N. Savory, K. Abe, K. Sode, and K. Ikebukuro, "Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing," Biosensors and Bioelectronics, Vol. 26, no. 4, pp. 1386-1391, 2010.